Home » Topics » Regulatory

Regulatory
RSS

Nadolol/isosorbide monohydrate combination prevents rebleeding

June 28, 1996

Gabitril approved in France as add-on therapy

June 28, 1996

Depakote receives FDA approval for new indication

June 28, 1996

Virulizin undergoes phase I/II in pancreatic cancer

June 28, 1996

Eulexin is FDA-approved for new indication

June 28, 1996

DepoCyt earns positive phase III results

June 28, 1996

Zithromax approved by FDA for new indication

June 28, 1996

Viramune receives accelerated FDA approval

June 28, 1996

Connective Therapeutics to develop new formulation of betamethasone valerate

June 28, 1996

Anakinra claimed for pancreatitis

June 21, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for April 15, 2025.
Biopharma exempt from US reciprocal tariffs, but not untouched
BioWorld
At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...
ADPD 2025: Unlocking GLP-1's potential in neurodegeneration
BioWorld
At the recently launched Alzheimer’s & Parkinson’s Diseases Conference held in Vienna, Lotte Bjerre Knudsen from Novo Nordisk A/S, who has extensive experience in...
ADPD 2025: Novel treatment modalities in neurodegenerative disorders
BioWorld Science
The current treatment strategies for neurodegenerative diseases focus on targeting Aβ in Alzheimer’s disease (AD), α-synuclein aggregates in Parkinson’s disease...